Skip to content
Tenderpoints
Tenderpoints™Hub
Severe Agitation (Chemical Restraint)

Droperidol 5–10 mg IM/IV OR Midazolam 5–10 mg IM OR 'B52' (Haldol 5mg + Ativan 2mg + Benadryl 50mg)

Violent/Excited Delirium

Ketamine 4–5 mg/kg IM (dissociation in 2–4 min) | Maintain airway & monitor ETCO2

Acute Dystonic Reaction

Diphenhydramine 50 mg IV/IM OR Benztropine 1–2 mg IV/IM (instant relief in 5–15 min)

NMS (Lead-Pipe Rigidity)

Stop neuroleptics | Aggressive cooling | Dantrolene 1–2.5 mg/kg IV + Bromocriptine 2.5–5 mg

Serotonin Syndrome (Clonus)

Benzodiazepines IV + Cyproheptadine 12 mg PO | Neuromuscular paralysis if temp > 41°C

Physical Restraint Mandatory Labs

Whenever physical restraints are placed, combativeness triggers severe rhabdomyolysis -> MANDATORY stat baseline & serial CPK, BMP (screen for lethal hyperkalemia K+ > 7), urinalysis for myoglobinuria, and 12-lead ECG; initiate IV crystalloid 200–300 mL/hr targeting urine output > 2–3 mL/kg/hr.

Bottom-Line Clinical Pearl

In violent, uncooperative agitation with excited delirium, Ketamine (4–5 mg/kg IM) provides rapid dissociation within 2–4 minutes; monitor capnography and airway closely. Neuroleptic Malignant Syndrome (lead-pipe rigidity, hyperthermia, CK elevation) requires Dantrolene and Bromocriptine. Serotonin syndrome (clonus, hyperreflexia, tremor) requires Benzodiazepines and Cyproheptadine.

1. Rapid Triage & Richmond Agitation-Sedation Scale (RASS)

The agitated patient poses an immediate physical risk to themselves and ED staff. Assessment begins with the Richmond Agitation-Sedation Scale (RASS) to grade severity: +1 (Anxious/Restless), +2 (Frequent non-purposeful movement), +3 (Pulls at tubes/combative), +4 (Overtly combative, violent, immediate staff danger).

Severity/RASSPatient PresentationDe-escalation & Pharmacotherapy Pathway
Mild (+1)Anxious, restless, verbal pacingVerbal de-escalation: offer food/drink, quiet room, open door, unhurried posture. Oral Lorazepam 1–2 mg or Olanzapine 5–10 mg ODT.
Moderate (+2 to +3)Combative, uncooperative with oral medsIntramuscular chemical restraint: Droperidol 5 mg IM OR Haloperidol 5 mg + Lorazepam 2 mg + Diphenhydramine 50 mg ('B52').
Severe/Violent (+4)Immediate danger to self/staff, physical violence, excited deliriumRapid dissociation: Ketamine 4–5 mg/kg IM (onset 2–4 min) OR Midazolam 10 mg IM. Place on continuous pulse oximetry, cardiac monitor, and capnography.

2. Rapid Chemical Restraint Formulations

MedicationDose & RouteOnset of SedationClinical Pearls & Safety
Droperidol5–10 mg IM (or 2.5–5 mg IV)5–10 minutesFirst-line agent in many EDs; faster onset and less redosing than haloperidol. Black box QT warning exists, but evidence shows extremely low torsades risk in acute ED sedation.
B52 CocktailHaloperidol 5 mg + Lorazepam 2 mg + Diphenhydramine 50 mg IM15–30 minutesClassic gold-standard combination. Haloperidol provides dopamine blockade, Lorazepam provides GABA-mediated sedation, Diphenhydramine prevents acute dystonic reactions.
Ketamine4–5 mg/kg IM (or 1–2 mg/kg IV)2–4 minutesIdeal for hyperactive delirium with severe agitation. Rapid dissociation preserving airway reflexes. Post-dissociation laryngospasm and emergence agitation treated with low-dose midazolam.
Midazolam5–10 mg IM5–10 minutesFast-acting benzodiazepine; risk of respiratory depression, especially if combined with alcohol or opioids. Have bag-valve-mask ready.
Olanzapine (Zyprexa)5–10 mg IM (or 10 mg ODT)15 minutesEffective atypical antipsychotic with low EPS risk. DO NOT co-administer parenteral olanzapine with parenteral benzodiazepines (black box fatal cardiorespiratory collapse).

3. Neuroleptic Malignant Syndrome (NMS) vs. Serotonin Syndrome

Both conditions present with fever, autonomic instability, and altered mental status, but their neuromuscular examinations and management differ dramatically.

Diagnostic FeatureNeuroleptic Malignant Syndrome (NMS)Serotonin Syndrome (SS)
Offending AgentsDopamine D2 receptor antagonists (Haloperidol, Fluphenazine, Metoclopramide) OR sudden withdrawal of L-dopaSerotonergic agents (SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Fentanyl, MDMA, Linezolid, St. John's Wort)
Onset & TimelineGradual over 1 to 3 days (or weeks)RAPID: Onset within 6 to 24 hours of drug initiation or dose increase
Neuromuscular FindingsSEVERE 'LEAD-PIPE' RIGIDITY; hyporeflexia, bradykinesia, cogwheelingHYPERREFLEXIA & CLONUS (spontaneous, inducible, or ocular clonus); tremor; myoclonus
Pupils & Bowel SoundsNormal pupils, normal/decreased bowel soundsMYDRIASIS (dilated pupils), HYPERACTIVE bowel sounds, diarrhea
Laboratory HallmarksMarked Creatine Kinase elevation (> 1,000–50,000 U/L), leukocytosis (10,000–40,000), metabolic acidosisMild CK elevation (from seizure/hyperactivity); otherwise unrevealing
Specific Antidotes1. Dantrolene 1–2.5 mg/kg IV (ryanodine antagonist) 2. Bromocriptine 2.5–5 mg PO/NG q8h (dopamine agonist)1. Cyproheptadine 12 mg PO initial dose, then 2 mg q2h 2. IV Benzodiazepines (titrated aggressively)

Critical Pitfall / Contraindication

Hyperthermia Alert: If core temperature exceeds 41.1°C (106°F) in either NMS or Serotonin Syndrome, end-organ brain damage and disseminated intravascular coagulation (DIC) ensue rapidly. Immediately paralyze with Rocuronium (1.2 mg/kg), perform endotracheal intubation to halt skeletal muscle heat production, and initiate aggressive evaporative and ice-water cooling. NEVER use Succinylcholine (causes fatal hyperkalemic cardiac arrest in muscle rigidity states).

4. Acute Dystonic Reactions

Sudden, involuntary, painful sustained contractions of muscle groups occurring hours to days following exposure to dopamine-blocking agents (typical antipsychotics, Metoclopramide, Compazine, Promethazine).

  • Common Manifestations: Torticollis (neck twisting), Oculogyric crisis (fixed upward eye deviation), Trismus (jaw clenching), Opisthotonus (severe back arching), Laryngeal dystonia (stridor and acute airway obstruction — true emergency).
  • Immediate Treatment: Diphenhydramine 50 mg IV/IM OR Benztropine (Cogentin) 1–2 mg IV/IM. Symptoms typically resolve within 5–15 minutes.
  • Discharge Prescription: Prescribe oral Benztropine 1–2 mg PO BID (or oral Diphenhydramine 25–50 mg TID) for 48–72 hours to prevent delayed recurrence as the offending neuroleptic clears.

5. Emergency Medical Clearance & Organic Exclusion

Before accepting a diagnosis of psychiatric decompensation, the emergency physician must systematically exclude medical and toxicologic etiologies ('medical clearance').

Medical Etiology ClueDifferential Diagnosis to Rule OutRequired ED Workup
Age > 40 with first psychiatric breakIntracranial mass, stroke, early dementia, autoimmune encephalitisNon-contrast CT head, comprehensive metabolic panel, thyroid panel (TSH)
Abnormal Vital Signs (Fever, Tachycardia, Hypoxia)Sepsis, meningitis, encephalitis, thyroid storm, pheochromocytoma, hypoxiaPulse oximetry, CBC, blood cultures, urinalysis, lumbar puncture if meningismus
Fluctuating level of consciousnessDelirium (metabolic, toxic, infectious)Fingerstick glucose (FIRST TEST), electrolyte panel, ammonia, ABG
Visual or Tactile HallucinationsSubstance intoxication (cocaine, methamphetamine, PCP), alcohol withdrawal (DTs)Urine drug screen, serum alcohol level, CIWA scoring, ECG for QTc prolongation
Focal Neurologic DeficitAcute ischemic stroke, intracranial hemorrhage, subdural hematomaStat non-contrast head CT, code stroke evaluation

6. Physical Restraints: Mandatory Laboratory Workup & Rhabdomyolysis Protocol (CPK, BMP, UA)

When physical restraints (4-point or leather limb restraints) are applied to an acutely agitated or combative patient, the patient frequently continues to struggle with sustained isometric muscle contractions against the non-yielding restraints. This intense, unyielding mechanical resistance produces rapid, severe rhabdomyolysis, massive sarcolemmal breakdown, acute myoglobinuric tubular necrosis, and life-threatening hyperkalemic cardiac arrest ($K^+ > 7.0$–$8.0$ mEq/L).

Mandatory Order / Diagnostic StepClinical Rationale & ThresholdImmediate Action & Protocol
Serum Creatine Kinase (CPK / CK)Baseline stat level upon application of restraints; recheck at 6, 12, and 24 hours (CPK peaks 24–72h post-struggle). Normal: 30–200 U/L. Rhabdomyolysis defined as CPK > 1,000 U/L or > 5x ULN; severe injury > 5,000–10,000+ U/L.If CPK > 1,000 U/L or if prolonged physical struggle occurred, initiate aggressive IV isotonic crystalloid (Lactated Ringer's 200–300 mL/hr) targeting urine output > 200–300 mL/hr (or 2–3 mL/kg/hr) to wash out obstructing myoglobin casts.
Basic Metabolic Panel (BMP)Monitor serum potassium ($K^+$), BUN, and serum creatinine. Hyperkalemic asystole is the leading cause of sudden, unexpected death in restrained patients.Stat 12-lead ECG if $K^+ > 5.5$ mEq/L or any cardiac arrhythmia. If peaked T waves or QRS widening occur: administer Calcium Gluconate 3 g IV (or Calcium Chloride 1 g IV) stat, followed by regular Insulin 10 units IV + D50W 50 mL.
Urinalysis (Dipstick + Microscopy)Orthotolidine reagent detects heme in both hemoglobin and myoglobin.Classic diagnostic hallmark of myoglobinuria: Urinalysis dipstick is strongly positive (3+ to 4+) for 'blood', but microscopic examination reveals few or zero RBCs (0–2 RBCs/HPF). Confirm with dark tea-colored or cola-colored urine.
12-Lead Electrocardiogram (ECG)Evaluate for hyperkalemia conduction defects and baseline QTc interval prior to neuroleptic administration.Look for tall, peaked, narrow T waves, PR prolongation, flattening of P waves, and intraventricular conduction delay (QRS widening). Repeat ECG post-sedation.
Positional Safety & ObservationProne positioning during restraint causes fatal positional asphyxia within 60–90 seconds.NEVER restrain patients in the prone (face-down) position! Maintain in supine or lateral recovery position with head elevated 30°. Document continuous pulse oximetry, capnography, neurovascular checks q15m, and active physician re-evaluation for restraint removal every 1 hour.

Critical Pitfall / Contraindication

The Restraint Illusion Board Trap: An agitated, combative patient in physical restraints who suddenly 'calms down' or becomes quiet and lethargic has NOT achieved spontaneous behavioral resolution! This patient is in catastrophic physiologic collapse from severe lactic acidosis (pH < 7.0), acute hyperkalemia, or positional asphyxiation. Immediately check a pulse, assess chest excursion, verify pulse oximetry, and obtain a stat venous blood gas and serum CPK!

COMAT & COMLEX Shelf Drill 5 Targeted Questions • Untimed Tutor Mode

Test Your Acute Agitation, Excited Delirium & Psych Emergencies Clinical Acumen

Directly launch an active-recall practice block from our validated question bank with comprehensive explanations and distractor analyses.

COMAT EM Center
High-Yield Board Pearl & Trap

Distinguish primary life-threats from mimics. On board exams (COMLEX Level 1, 2-CE, 3 & USMLE), initial stabilizing interventions (airway, IV access, non-invasive ventilation, empiric reversal) always take precedence over diagnostic imaging.

Osteopathic & Autonomic Bridge

Evaluate autonomic tone: Sympathetic viscerosomatics (T1–L2) cause acute paraspinal tissue texture changes (erythema, bogginess, hypertonicity). Suboccipital release (CN X Vagus) and rib raising normalize autonomic outflow and thoracic cage mechanics.